Measurement of pancreatic stone protein in the identification and management of sepsis.

Eggimann, Philippe; Que, Yok-Ai; Rebeaud, Fabien (2019). Measurement of pancreatic stone protein in the identification and management of sepsis. Biomarkers in medicine, 13(2), pp. 135-145. Future Medicine 10.2217/bmm-2018-0194

Preview

Text 2019 - Eggimann - BMM - PMID 30672312.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND). Download (1MB) | Preview

Sepsis is a life-threatening syndrome characterized by a dysregulated host response to an infection resulting in multiple organ dysfunctions. Early diagnosis and management of sepsis is key to improve patient outcome but remains challenging. Despite extensive research, only few biomarkers have so far proven to be helpful in the diagnosis of sepsis. A novel protein biomarker, the pancreatic stone protein (PSP), is showing great promises. Several lines of evidences suggest that PSP has a higher diagnostic performance for the identification of sepsis than procalcitonin and C-reactive protein, and a strong prognostic value to predict unfavorable outcome at admission to intensive care unit. This review summarizes the current knowledge on the molecular mechanisms of PSP function and the clinical evidences available to highlight the relevance of this protein in the diagnosis and prognosis of sepsis.

Interest & Impact

Downloads

241 since deposited on 29 Aug 2019
30 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item